UPDATE: JPMorgan Resumes Myriad Genetics (MYGN) at Underweight
Tweet Send to a Friend
(Updated - March 31, 2014 1:00 PM EDT)
JPMorgan resumed coverage on Myriad Genetics (NASDAQ: MYGN) with an Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan resumed coverage on Myriad Genetics (NASDAQ: MYGN) with an Underweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
